https | 合法醫療器材資訊網

沒有這個頁面的資訊。

The Food and Drug Administration (FDA) has expanded the indication for Stryker’s Trevo Retriever as a front-line treatment for patients experiencing acute ischemic stroke up to 24 hours from symptom onset – increasing the treatment window by 18 hours. The expanded indication of Stryker’s clot-removal device is in line with the recently updated treatment guidelines from the American Heart Association and American Stroke Association, and has the potential to reduce disability and improve quality of life for tens of thousands of additional stroke patients each year.

“The 24-hour indication opens the treatment window to patients whose stroke would previously have progressed until all the brain tissue surrounding the affected arteries was dead, leaving them with a life of significant disabilities,” said Dr. Raul Nogueira of Grady Memorial Hospital and Emory University. “These patients now have a much better ...